Expansion
The initial round of testing has been successful for the nation’s first Corona tablet. The quality and potency of the tablet used in the trial were assessed at the Central Drugs Lab (CDL) in Kasauli. VXA-GOV 2 Enteric Coated Tablet has effectively completed the initial stage in this. Now its clinical trial will start. This tablet has been imported from America by Synjin Company of Bangalore. The company has claimed to launch this drug in the market by the end of this year. If all the studies are successful, it is said that the corona patient’s condition would improve after taking this drug, and he will become healthy in a few days.
After its arrival on the market, getting rid of the corona vaccine will also get rid of it and soon antibodies will start forming in the body. Tablet quality and potency are tested at CDL Kasauli. Before being introduced to the market, the Corona tablet must pass two additional testing stages. Along with this, there will also be a clinical trial of the vaccine. The company will have to report this to the Drug Controller General of India (DCGI). The trial of the tablet began in May at CDL Kasauli. If it meets all the criteria then it will be the country’s first corona tablet. This has been confirmed on the website of CDL Kasauli.
The second trial will start
After passing the first phase on August 10, the second trial will start on August 10. For this the process is being completed by the company. Not only this, the company will again send its trial batch to CDL Kasauli for testing.
These vaccines have been approved
So far in India, DCGI has approved other corona vaccines including Kovishield, Covaccine, Sputnik-V, Modern, Johnson & Johnson, Jayakov D, Corbevax, Kovovax, and Sputnik Lite.
| |
  Facebook Page |          Click Here |
|  Twitter       |           Click Here |
| Â Instagram | Â Â Â Â Â Â Â Â Â Click Here |
| Â Google News | Â Â Â Â Â Â Â Â Â Click Here |
